Protara Therapeutics (TARA) Interest & Investment Income (2014 - 2026)
Protara Therapeutics (TARA) recorded quarterly Interest & Investment Income of $1.7 million in Q1 2026, up 897.59% quarter-over-quarter from $166000.0 in Q4 2025, and up 6.5% on a YoY basis from $1.6 million in Q1 2025.
Protara Therapeutics (TARA) Interest & Investment Income (2014 - 2026) Analysis & Trends
Protara Therapeutics' Interest & Investment Income history runs 12 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 6.5% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $4.5 million (up 10.71% YoY), while the FY2025 annual figure was $5.0 million, up 51.02% from the prior year.
- Interest & Investment Income was $1.7 million for Q1 2026 at Protara Therapeutics, up from $166000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.7 million in Q1 2026 to a low of $119000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $827470.6 across 5 years, with a median of $820000.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income jumped 5020.0% in 2022, then tumbled 62.07% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $632000.0 in 2022, then increased by 29.75% to $820000.0 in 2023, then sank by 62.07% to $311000.0 in 2024, then slumped by 46.62% to $166000.0 in 2025, then soared by 897.59% to $1.7 million in 2026.
- The last three Interest & Investment Income figures came in at $1.7 million (Q1 2026), $166000.0 (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Protara Therapeutics | 216.35 Mn | 216.35 Mn | - | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | 166,000.00 |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 311,000.00 |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 756,000.00 |
| Dec 31, 2023 | 820,000.00 |
| Sep 30, 2023 | 840,000.00 |
| Jun 30, 2023 | 846,000.00 |
| Mar 31, 2023 | 605,000.00 |
| Dec 31, 2022 | 632,000.00 |
| Sep 30, 2022 | 283,000.00 |
| Jun 30, 2022 | 512,000.00 |
| Mar 31, 2022 | 119,000.00 |
| Dec 31, 2021 | 59,000.00 |
| Sep 30, 2021 | 53,000.00 |
| Jun 30, 2021 | 10,000.00 |